|
|||||
|
|
De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort |
|
| Authors: | Yu-Wen Cai MD Zhi-Ming Shao MD Ke-Da Yu MD PhD |
| Affiliation: | 1. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Shanghai Medical College, Fudan University, Shanghai, China;2. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Shanghai Key Laboratory of Breast Cancer, Shanghai, China;3. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China |
| Abstract: | |
| Keywords: | breast cancer endocrine therapy estrogen receptor low-positive short-term |
